SFG
PCRX icon

Steward Financial Group’s Pacira BioSciences PCRX Stock Holding History

Steward Financial Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+8
New +$288 ﹤0.01% 1497
2022
Q3 		– Sell
-2
Closed – – 967
2022
Q2 		$0 Buy
+2
New +$131 ﹤0.01% 1268

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Steward Financial Group's PCRX Position: Q3 2023 in Review

Steward Financial Group opened a new position in Pacira BioSciences (PCRX) in Q3 2023: 8 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1497 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in PCRX as recently as Q2 2022.

Steward Financial Group first reported a position in PCRX in Q2 2022 and has held it in 2 quarters since. 261 funds tracked by Wall St. Rank hold PCRX as of Q3 2023.

  • Steward Financial Group held 8 shares of Pacira BioSciences worth $0 as of Q3 2023.
  • Pacira BioSciences was a new Steward Financial Group position in Q3 2023.
  • Pacira BioSciences made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1497 holding.
  • Steward Financial Group first reported a position in Pacira BioSciences in Q2 2022 and has held it in 2 quarters since.
  • 261 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.